Log in
Pharmacology · Antiarrhythmic agents

Cardiac Electrophysiology and Arrhythmia Pathogenesis

Arrhythmias are heart rhythm disorders arising from disruptions in automaticity and conduction processes. Their pathogenesis is based on changes in ionic currents in myocardial cells, which distorts the normal action potential and disrupts the synchrony of cardiac contractions. Understanding these mechanisms is essential for the correct choice of antiarrhythmic therapy.

Resting potentialIn Purkinje fibers, it is about –90 mV, and in pacemaker cells, it is about –55 mV.
Conduction velocityMaximum in the bundle of His (up to 5 m/s), minimum in the AV node (0.02–0.05 m/s).
Antiarrhythmic drugsDivided into 4 main classes depending on their effect on specific ion channels and receptors.
Proarrhythmic effectAntiarrhythmic drugs themselves are capable of paradoxically provoking rhythm disorders.
5 min readFor medical studentsUpdated 09/24/2026
Material prepared by WhiteCoat Pro editorial team based on platform study guidesReviewed by medical editor: Aulov A. A., general practitioner · 09/24/2026

Conduction system and its regulation

The heart functions in a coordinated manner thanks to a strict hierarchy of pacemakers. The sinus node sets the normal rate, while the atrioventricular (AV) node acts as a secondary pacemaker (generating 40–60 impulses per minute).

The AV junction performs a crucial filter function. Conduction velocity in its penetrating fibers drops to 0.02–0.05 m/s. This allows the impulse to pass in only one direction (antegrade) and protects the ventricles from overload during high atrial excitation rates. Fibrous tissue between the chambers acts as an electrical insulator, preventing retrograde return of the impulse.

Next, the signal travels along the bundle of His, where velocity is maximal (1.5–5 m/s), and spreads through the Purkinje fibers. These terminal branches contain myosin and are capable of contracting along with the working myocardium, providing a powerful systole.

Nervous regulation is carried out by the autonomic nervous system:

  • Parasympathetic (n. vagus): via $M_2$-cholinergic receptors, it suppresses automaticity and conduction. The right branch controls the sinus node, the left — the AV node. The ventricles are not innervated by the vagus nerve.
  • Sympathetic: via $\beta_1$-adrenergic receptors, it increases automaticity and accelerates conduction, affecting the entire myocardium.

Action potential of a Purkinje fiber

The electrophysiological model of a conduction system cell includes five phases, each of which depends on the movement of specific ions:

  1. Phase 0 (Rapid depolarization): Upon reaching the threshold potential (–60 mV), rapid sodium channels open. An avalanche-like influx of $Na^+$ changes the membrane charge to +35 mV. The duration of this phase determines conduction.
  2. Phase 1 (Early repolarization): Brief efflux of $K^+$.
  3. Phase 2 (Plateau): Slow influx of $Ca^{2+}$ maintains the positive membrane charge, preventing rapid repolarization.
  4. Phase 3 (Final repolarization): Massive efflux of $K^+$ returns the cell to the resting potential (–90 mV).
  5. Phase 4 (Spontaneous diastolic depolarization): Slow influx of $Na^+$ and $K^+$. The rate of this process determines the cell's automaticity.
Test your knowledge on the topicTasks from the «Pharmacology» course bank — instant answers and explanations.

Features of the nodes and refractoriness

In the cells of the sinus and AV nodes, the mechanisms of impulse generation are different. The resting potential here is about –55 mV, which causes most rapid sodium channels to be inactivated. Phases 0 and 4 are provided by the inward calcium current. This current is initiated by a preliminary sodium influx through specific non-selective cationic channels — If-channels (funny channels), the operation of which forms the basis of normal automaticity.

To protect the heart from tetanic contraction and pathological impulse circulation (reentry), an effective refractory period (ERP) exists. It encompasses phases 0, 1, 2, and the beginning of phase 3. During this time, the cell is absolutely non-excitable and cannot conduct another full-fledged impulse.

Pathogenesis and pharmacotherapy of arrhythmias

Arrhythmias arise against the background of hypoxia, metabolic disorders, or endocrine failures (e.g., in thyrotoxicosis). According to their developmental mechanism, they are divided into blocks (decreased conduction), extrasystoles (increased automaticity), and re-entry arrhythmias — reentry (impaired conduction).

To treat tachyarrhythmias, 4 main classes of drugs are used:

  • Class I: Sodium channel blockers (affect phases 0 and 4, reduce conduction).
  • Class II: $\beta$-blockers (have a non-competitive effect, inhibit adenylyl cyclase).
  • Class III: Potassium channel blockers (prolong phase 3 and ERP).
  • Class IV: Slow calcium channel blockers (reduce automaticity in the nodes).

For bradyarrhythmias and heart blocks, rate-accelerating agents are used: M- anticholinergics and $\beta$-agonists.

Briefly: answers to topical questions

What subclasses are distinguished within Class I antiarrhythmic drugs and which specific medications belong to them?

Within Class I antiarrhythmic drugs (sodium channel blockers), three subclasses are distinguished: IA, IB, and IC. The division is based on the nuances of channel binding, effects on cardiac electrophysiological parameters, and clinical application. Specific medications belonging to each of the subclasses are not listed in the provided materials.

What is the exact electrophysiological mechanism behind the formation of a re-entry excitation loop?

The mechanism of formation of a re-entry excitation loop (reentry) is based on the occurrence of a unilateral conduction block.

  • Orthodromic conduction — the impulse cannot pass through the damaged refractory fiber, but passes through an adjacent healthy pathway.
  • Antidromic return — upon reaching the distal regions, the impulse returns retrogradely to the damaged area.
  • Circuit closure — by the time of return, the damaged tissue exits refractoriness and conducts the impulse in the reverse direction.

As a result, the impulse re-enters the undamaged fiber, forming a closed loop of circulation.

What is the mechanism of the proarrhythmic action of antiarrhythmic drugs?

The mechanism of the proarrhythmic action of antiarrhythmic drugs lies in their ability to paradoxically provoke rhythm disorders. Two main pathways are distinguished:

  • Vagolytic mechanism — blockade of the vagus nerve increases sinus node automaticity and facilitates conduction through the AV junction, which enhances ventricular arrhythmia.
  • Effect on reentry — conduction suppression can paradoxically shorten the impulse movement trajectory. Movement along the "short circle" occurs faster, causing acceleration of the re-entry rhythm.

A risk factor is the combination of structural heart changes and electrical instability.

How to memorize

Relationship between AP phases and ions: 0 — Sodium (inward, conduction), 2 — Calcium (inward, plateau), 3 — Potassium (outward, repolarization). Phase 4 (automaticity) — function of If-channels.

Class and exam questions

Why is the AV node called a "filter"?

Conduction velocity in its penetrating fibers is minimal (0.02–0.05 m/s). This delays extra impulses during atrial tachycardia, transmitting them only antegrade and protecting the ventricles from overload.

What is the effective refractory period (ERP)?

This is the time (phases 0, 1, 2, and early 3) during which a cell cannot generate a new full-fledged action potential. Prolongation of ERP protects the myocardium from extrasystoles and circus movement waves of excitation (reentry).

What is the difference between the action potential of the sinus node and Purkinje fibers?

In pacemaker cells, the resting potential is higher (–55 mV), rapid sodium channels do not function, and depolarization and automaticity are provided by the calcium ion current and the operation of If-channels.

Something unclear? Ask the AIThe AI tutor has read the material on "Cardiac Electrophysiology and Arrhythmia Pathogenesis" and will explain it in simple terms.

What else to study on this topic

  • Detailed mechanism of action of each of the 4 classes of antiarrhythmic drugs
  • Use of additional agents in arrhythmias (adenosine, cardiac glycosides, potassium and magnesium preparations)
  • The role of fibrous tissue in the electrical isolation of the atria from the ventricles
  • Clinical-pathogenetic correlation: the relationship between the developmental mechanism and the form of arrhythmia

Master the entire topic in the «Pharmacology» course

This is a summary. The course covers everything tested in classes and exams.

  • Complete study guide on "Cardiac Electrophysiology and Arrhythmia Pathogenesis" and another 5,304 pages of the subject
  • Assignments and quizzes after every topic — just like in a colloquium
  • AI tutor answers questions on the topic anytime
  • 116 video lessons on the subject

Other topics in the "Antiarrhythmic Agents" section

Entire section «Antiarrhythmic agents»

Free video lessons: pharmacologyShort lessons with study notes — no registration required.

Watch lessons

Prepared by WhiteCoat Pro faculty in accordance with the medical school curriculum. For educational purposes only.